3,436 research outputs found
From Koszul duality to Poincar\'e duality
We discuss the notion of Poincar\'e duality for graded algebras and its
connections with the Koszul duality for quadratic Koszul algebras. The
relevance of the Poincar\'e duality is pointed out for the existence of twisted
potentials associated to Koszul algebras as well as for the extraction of a
good generalization of Lie algebras among the quadratic-linear algebras.Comment: Dedicated to Raymond Stora. 27 page
Administration of intravenous iron formulations induces complement activation in-vivo
Background: Intravenous (IV) iron is widely used to treat anemia in chronic kidney disease patients. Previously, iron formulations were shown to induce immune activation in-vitro. The current study aimed to investigate the effect of IV iron on complement activation in-vivo, and whether this subsequently induces inflammation and/or oxidative stress. Methods: Two distinct patient groups were included: 51 non-dialysis and 32 dialysis patients. The non-dialysis group received iron sucrose or ferric carboxymaltose, based on physicians’ choice. Plasma samples were collected prior to and 1 h after completion of IV iron infusion. The dialysis group received iron sucrose exclusively. Plasma samples were collected at the start and end of two consecutive hemodialysis sessions, one with and one without IV iron. Finally, plasma levels of MBL, C1q, properdin, factor D, sC5b-9, MPO, PTX3 were assessed by ELISA. Results: In the non-dialysis group, sC5b-9 levels significantly increased after IV iron by 32%, while levels of factor D and MBL significantly dropped. Subgroup analysis demonstrated that iron sucrose induced complement activation whereas ferric carboxymaltose did not. In the dialysis group, levels of sC5b-9 significantly increased by 46% during the dialysis session with IV iron, while factor D levels significantly fell. Furthermore, the relative decrease in factor D by IV iron correlated significantly with the relative increase in sC5b-9 by IV iron. MPO levels rose significantly during the dialysis session with IV iron, but not in the session without iron. Moreover, the relative increase in MPO and sC5b-9 by IV iron correlated significantly. PTX3 levels were not affected by IV iron. Conclusions: Iron sucrose but not ferric carboxymaltose, results in complement activation possibly via the lectin and alternative pathway partially mediating oxidative stress but not inflammation.Conflict of Interest Statement: CG received speaking fees and research funding from Vifor Pharma
Structures and waves in a nonlinear heat-conducting medium
The paper is an overview of the main contributions of a Bulgarian team of
researchers to the problem of finding the possible structures and waves in the
open nonlinear heat conducting medium, described by a reaction-diffusion
equation. Being posed and actively worked out by the Russian school of A. A.
Samarskii and S.P. Kurdyumov since the seventies of the last century, this
problem still contains open and challenging questions.Comment: 23 pages, 13 figures, the final publication will appear in Springer
Proceedings in Mathematics and Statistics, Numerical Methods for PDEs:
Theory, Algorithms and their Application
Supersymmetric Higgs Yukawa Couplings to Bottom Quarks at next-to-next-to-leading Order
The effective bottom Yukawa couplings are analyzed for the minimal
supersymmetric extension of the Standard Model at two-loop accuracy within
SUSY-QCD. They include the resummation of the dominant corrections for large
values of tg(beta). In particular the two-loop SUSY-QCD corrections to the
leading SUSY-QCD and top-induced SUSY-electroweak contributions are addressed.
The residual theoretical uncertainties range at the per-cent level.Comment: 25 pages, 9 figures, added comments and references, typos corrected,
results unchanged, published versio
Phenomenological Implications of Deflected Mirage Mediation: Comparison with Mirage Mediation
We compare the collider phenomenology of mirage mediation and deflected
mirage mediation, which are two recently proposed "mixed" supersymmetry
breaking scenarios motivated from string compactifications. The scenarios
differ in that deflected mirage mediation includes contributions from gauge
mediation in addition to the contributions from gravity mediation and anomaly
mediation also present in mirage mediation. The threshold effects from gauge
mediation can drastically alter the low energy spectrum from that of pure
mirage mediation models, resulting in some cases in a squeezed gaugino spectrum
and a gluino that is much lighter than other colored superpartners. We provide
several benchmark deflected mirage mediation models and construct model lines
as a function of the gauge mediation contributions, and discuss their discovery
potential at the LHC.Comment: 29 pages, 9 figure
Visual parameter optimisation for biomedical image processing
Background: Biomedical image processing methods require users to optimise input parameters to ensure high quality
output. This presents two challenges. First, it is difficult to optimise multiple input parameters for multiple
input images. Second, it is difficult to achieve an understanding of underlying algorithms, in particular, relationships
between input and output.
Results: We present a visualisation method that transforms users’ ability to understand algorithm behaviour by
integrating input and output, and by supporting exploration of their relationships. We discuss its application to a
colour deconvolution technique for stained histology images and show how it enabled a domain expert to
identify suitable parameter values for the deconvolution of two types of images, and metrics to quantify
deconvolution performance. It also enabled a breakthrough in understanding by invalidating an underlying
assumption about the algorithm.
Conclusions: The visualisation method presented here provides analysis capability for multiple inputs and outputs
in biomedical image processing that is not supported by previous analysis software. The analysis supported by our
method is not feasible with conventional trial-and-error approaches
Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor
Background:
Endothelin receptor antagonists inhibit the progression of many cancers, but research into their influence on glioma has been limited.
Methods:
We treated glioma cell lines, LN-229 and SW1088, and melanoma cell lines, A375 and WM35, with two endothelin receptor type B (ETRB)-specific antagonists, A-192621 and BQ788, and quantified viable cells by the capacity of their intracellular esterases to convert non-fluorescent calcein AM into green-fluorescent calcein. We assessed cell proliferation by labeling cells with carboxyfluorescein diacetate succinimidyl ester and quantifying the fluorescence by FACS analysis. We also examined the cell cycle status using BrdU/propidium iodide double staining and FACS analysis. We evaluated changes in gene expression by microarray analysis following treatment with A-192621 in glioma cells. We examined the role of ETRB by reducing its expression level using small interfering RNA (siRNA).
Results:
We report that two ETRB-specific antagonists, A-192621 and BQ788, reduce the number of viable cells in two glioma cell lines in a dose- and time-dependent manner. We describe similar results for two melanoma cell lines. The more potent of the two antagonists, A-192621, decreases the mean number of cell divisions at least in part by inducing a G2/M arrest and apoptosis. Microarray analysis of the effects of A-192621 treatment reveals up-regulation of several DNA damage-inducible genes. These results were confirmed by real-time RT-PCR. Importantly, reducing expression of ETRB with siRNAs does not abrogate the effects of either A-192621 or BQ788 in glioma or melanoma cells. Furthermore, BQ123, an endothelin receptor type A (ETRA)-specific antagonist, has no effect on cell viability in any of these cell lines, indicating that the ETRB-independent effects on cell viability exhibited by A-192621 and BQ788 are not a result of ETRA inhibition.
Conclusion:
While ETRB antagonists reduce the viability of glioma cells in vitro, it appears unlikely that this effect is mediated by ETRB inhibition or cross-reaction with ETRA. Instead, we present evidence that A-192621 affects glioma and melanoma viability by activating stress/DNA damage response pathways, which leads to cell cycle arrest and apoptosis. This is the first evidence linking ETRB antagonist treatment to enhanced expression of DNA damage-inducible genes
Activation of Human Stearoyl-Coenzyme A Desaturase 1 Contributes to the Lipogenic Effect of PXR in HepG2 Cells
The pregnane X receptor (PXR) was previously known as a xenobiotic receptor. Several recent studies suggested that PXR also played an important role in lipid homeostasis but the underlying mechanism remains to be clearly defined. In this study, we found that rifampicin, an agonist of human PXR, induced lipid accumulation in HepG2 cells. Lipid analysis showed the total cholesterol level increased. However, the free cholesterol and triglyceride levels were not changed. Treatment of HepG2 cells with rifampicin induced the expression of the free fatty acid transporter CD36 and ABCG1, as well as several lipogenic enzymes, including stearoyl-CoA desaturase-1 (SCD1), long chain free fatty acid elongase (FAE), and lecithin-cholesterol acyltransferase (LCAT), while the expression of acyl:cholesterol acetyltransferase(ACAT1) was not affected. Moreover, in PXR over-expressing HepG2 cells (HepG2-PXR), the SCD1 expression was significantly higher than in HepG2-Vector cells, even in the absence of rifampicin. Down-regulation of PXR by shRNA abolished the rifampicin-induced SCD1 gene expression in HepG2 cells. Promoter analysis showed that the human SCD1 gene promoter is activated by PXR and a novel DR-7 type PXR response element (PXRE) response element was located at -338 bp of the SCD1 gene promoter. Taken together, these results indicated that PXR activation promoted lipid synthesis in HepG2 cells and SCD1 is a novel PXR target gene. © 2013 Zhang et al
PGB pair production at LHC and ILC as a probe of the topcolor-assisted technicolor models
The topcolor-assisted technicolor (TC2) model predicts some light pseudo
goldstone bosons (PGBs), which may be accessible at the LHC or ILC. In this
work we study the pair productions of the charged or neutral PGBs at the LHC
and ILC. For the productions at the LHC we consider the processes proceeding
through gluon-gluon fusion and quark-antiquark annihilation, while for the
productions at the ILC we consider both the electron-positron collision and the
photon-photon collision. We find that in a large part of parameter space the
production cross sections at both colliders can be quite large compared with
the low standard model backgrounds. Therefore, in future experiments these
productions may be detectable and allow for probing TC2 model.Comment: 26 pages, 16 figures. slight changes in the text; notations for
curves changed; references adde
MFV Reductions of MSSM Parameter Space
The 100+ free parameters of the minimal supersymmetric standard model (MSSM)
make it computationally difficult to compare systematically with data,
motivating the study of specific parameter reductions such as the cMSSM and
pMSSM. Here we instead study the reductions of parameter space implied by using
minimal flavour violation (MFV) to organise the R-parity conserving MSSM, with
a view towards systematically building in constraints on flavour-violating
physics. Within this framework the space of parameters is reduced by expanding
soft supersymmetry-breaking terms in powers of the Cabibbo angle, leading to a
24-, 30- or 42-parameter framework (which we call MSSM-24, MSSM-30, and MSSM-42
respectively), depending on the order kept in the expansion. We provide a
Bayesian global fit to data of the MSSM-30 parameter set to show that this is
manageable with current tools. We compare the MFV reductions to the
19-parameter pMSSM choice and show that the pMSSM is not contained as a subset.
The MSSM-30 analysis favours a relatively lighter TeV-scale pseudoscalar Higgs
boson and with multi-TeV sparticles.Comment: 2nd version, minor comments and references added, accepted for
publication in JHE
- …